Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Kendle | Contract Pharma

What are you searching for?

Sign in
Breaking News, Promotions & Moves

Kendle

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Roberto J. Bitton, M.D. has been appointed project leader, Latin America, Kendle. In this role, he will provide medical and therapeutic expertise for Phase I-IV clinical development projects for the company’s biopharmaceutical customers, with an emphasis on oncology therapeutics. Dr. Bitton is a board-certified medical oncologist and has more than 20 years of academic, CRO and pharmaceutical industry experience. He has led clinical teams in every phase of the oncology drug development process.

“Oncology now ranks as the most researched therapeutic area worldwide in terms of drug development,” said Martha Feller, Ph.D., senior vice president, global clinical development, Kendle. “Dr. Bitton’s extensive oncology expertise will further strengthen our therapeutic experience in this significant and growing area of global clinical development.”

Dr. Bitton most recently served as medical manager, South Latin America Sub-Region for Novartis Oncology, where he was responsible for late phase and medical marketing. Prior to that, he served as associate medical director, leading the efforts for various cancer vaccines from R&D through Phase II trials for an independent pharmaceutical company in Argentina, and as a program leader in the clinical oncology department for Pharmacia-Upjohn in Milan, Italy.

“Dr. Bitton’s full-spectrum background in oncology is critically important as the focus in drug development continues to shift beyond simply bringing a new compound to market toward effectively managing the entire life cycle of each drug,” added Dr. Feller.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics